News

Dr. Chetan Chitnis, inventor of the EVI supported JAIVAC-1 malaria vaccine project, has received an Infosys award

The EC-funded, EVI coordinated project PHARVAT now has its own web site.

European stakeholders of vaccine research and development convened in Brussels yesterday. A private-public working group starts to prepare concrete proposals to strengthen Europe’s vaccine infrastructure.

The first vaccinations of the candidate malaria vaccine, JAIVAC-1, with Montanide ISA 720 VG as adjuvant, have been administered to the first group of volunteers in India.

Safety and immunogenicity of heterologous prime‐boost with the candidate malaria vaccines ChAd63 ME‐TRAP and MVA ME‐TRAP in healthy adults in East and West Africa

Heidelberg/Lelystad, July 2010 - European Vaccine Initiative (EVI, previously known as European Malaria Vaccine Initiative) and TuBerculosis Vaccine Initiative (TBVI) recently signed a Memorandum of Understanding (MoU) for enhanced collaboration

Integrating capacity-building and networking in the design and conduct of Phase I and II clinical trials of viral vectored candidate malaria vaccines in East and West African children and infants Malaria Vectored Vaccines Consortium (MVVC).

European Network of Vaccine Research and Development (TRANSVAC). This four year project with a budget of €9,900,000, which officially started on 1 October 2009, has thirteen consortium members.

World Malaria Day is commemorated on the 25th of April, each year. The declaration of this date by the World Health Organisation as World Malaria Day in 2008 has done much to give greater and deserved...